Home  /  Resource Library  /  Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open label, single-arm, phase 1-2 study

Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open label, single-arm, phase 1-2 study

Results of trial examining acalabrutinib for treatment of Richter transformation.